Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2004;94:28-36
Published online before print November 20, 2003, doi: 10.1161/01.RES.0000108264.67601.2C
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
94/1/28    most recent
01.RES.0000108264.67601.2Cv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Au-Yeung, K. K.W.
Right arrow Articles by O, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Au-Yeung, K. K.W.
Right arrow Articles by O, K.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Animal models of human disease
Right arrow Risk Factors
Right arrow Oxidant stress
Right arrow Mechanism of atherosclerosis/growth factors
(Circulation Research. 2004;94:28.)
© 2004 American Heart Association, Inc.


Molecular Medicine

Hyperhomocysteinemia Activates Nuclear Factor-{kappa}B in Endothelial Cells via Oxidative Stress

Kathy K.W. Au-Yeung, Connie W.H. Woo, Fion L. Sung, Johnny C.W. Yip, Yaw L. Siow, Karmin O

From the Department of Pharmacology (F.L.S., J.C.W.Y., Y.L.S., K.O), Faculty of Medicine, The University of Hong Kong, and National Centre for Agri-Food Research in Medicine (K.K.W.A-Y., C.W.H.W., Y.L.S., K.O.), Departments of Animal Science and Physiology, University of Manitoba, Canada.

Correspondence to Dr Karmin O, MD, PhD, Laboratory of Integrative Biology, NCARM, St Boniface Hospital Research Centre, R4032, 351 Tache Ave, Winnipeg, Manitoba R2H 2A6, Canada. E-mail karmino{at}sbrc.ca

Hyperhomocysteinemia is an independent risk factor for cardiovascular diseases. Our previous studies demonstrated an important interaction between nuclear factor-{kappa}B (NF-{kappa}B) activation and homocysteine (Hcy)-induced chemokine expression in vascular smooth muscle cells and macrophages. The objective of the present study was to investigate the in vivo effect of hyperhomocysteinemia on NF-{kappa}B activation and the underlying mechanism of Hcy-induced NF-{kappa}B activation in endothelial cells. Hyperhomocysteinemia was induced in Sprague-Dawley rats after 4 weeks of a high-methionine diet. The activated form of NF-{kappa}B and increased level of superoxide anions were detected in the endothelium of aortas isolated from hyperhomocysteinemic rats. The underlying mechanism of Hcy-induced NF-{kappa}B activation was investigated in human umbilical cord vein endothelial cells and in human aortic endothelial cells. Incubation of cells with Hcy (100 µmol/L) activated I{kappa}B kinases (IKK{alpha} and IKKß), leading to phosphorylation and subsequent degradation of I{kappa}B{alpha}. As a consequence, NF-{kappa}B nuclear translocation, enhanced NF-{kappa}B/DNA binding activity, and increased transcriptional activity occurred. Additional analysis revealed a marked elevation of superoxide anion levels in Hcy-treated cells. Treatment of cells with a superoxide anion scavenger (polyethylene glycol-superoxide dismutase) or I{kappa}B kinase inhibitor (prostaglandin A1) could prevent Hcy-induced activation of IKK kinases and NF-{kappa}B in endothelial cells. In conclusion, these results suggest that Hcy-induced superoxide anion production may play a potential role for NF-{kappa}B activation in the early stages of atherosclerosis in the vascular wall via activation of I{kappa}B kinases.


Key Words: homocysteine • nuclear factor-{kappa}B • I{kappa}B{alpha} • I{kappa}B kinase • superoxide




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
H. Stopper, A.-T. Treutlein, U. Bahner, N. Schupp, U. Schmid, A. Brink, A. Perna, and A. Heidland
Reduction of the genomic damage level in haemodialysis patients by folic acid and vitamin B12 supplementation
Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3272 - 3279.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. G. Mikael and R. Rozen
Homocysteine modulates the effect of simvastatin on expression of ApoA-I and NF-{kappa}B/iNOS
Cardiovasc Res, October 1, 2008; 80(1): 151 - 158.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P.-Y. Chang, S.-C. Lu, C.-M. Lee, Y.-J. Chen, T. A. Dugan, W.-H. Huang, S.-F. Chang, W. S.L. Liao, C.-H. Chen, and Y.-T. Lee
Homocysteine Inhibits Arterial Endothelial Cell Growth Through Transcriptional Downregulation of Fibroblast Growth Factor-2 Involving G Protein and DNA Methylation
Circ. Res., April 25, 2008; 102(8): 933 - 941.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
Y. Li, C. Jiang, G. Xu, N. Wang, Y. Zhu, C. Tang, and X. Wang
Homocysteine Upregulates Resistin Production From Adipocytes In Vivo and In Vitro
Diabetes, April 1, 2008; 57(4): 817 - 827.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. W. H. Woo, Y. L. Siow, and K. O
Homocysteine Induces Monocyte Chemoattractant Protein-1 Expression in Hepatocytes Mediated via Activator Protein-1 Activation
J. Biol. Chem., January 18, 2008; 283(3): 1282 - 1292.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S.-Y. Hwang, C. W. H. Woo, K. K. W. Au-Yeung, Y. L. Siow, T. Y. Zhu, and K. O
Homocysteine stimulates monocyte chemoattractant protein-1 expression in the kidney via nuclear factor-{kappa}B activation
Am J Physiol Renal Physiol, January 1, 2008; 294(1): F236 - F244.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. A. Carluccio, M. A. Ancora, M. Massaro, M. Carluccio, E. Scoditti, A. Distante, C. Storelli, and R. De Caterina
Homocysteine induces VCAM-1 gene expression through NF-{kappa}B and NAD(P)H oxidase activation: protective role of Mediterranean diet polyphenolic antioxidants
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2344 - H2354.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
S. Sahin, F.B. Aksungar, A.E. Topkaya, Z. Yildiz, U.T. Boru, S. Ayalp, and S. Karsidag
Increased plasma homocysteine levels in multiple sclerosis
Multiple Sclerosis, August 1, 2007; 13(7): 945 - 946.
[PDF]


Home page
J Am Coll CardiolHome page
C. Prontera, N. Martelli, V. Evangelista, E. D'Urbano, S. Manarini, A. Recchiuti, A. Dragani, C. Passeri, G. Davi, and M. Romano
Homocysteine Modulates the CD40/CD40L System
J. Am. Coll. Cardiol., June 5, 2007; 49(22): 2182 - 2190.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
G. A. Prathapasinghe, Y. L. Siow, and K. O
Detrimental role of homocysteine in renal ischemia-reperfusion injury
Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1354 - F1363.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Q. H. Meng, G. Yang, W. Yang, B. Jiang, L. Wu, and R. Wang
Protective Effect of Hydrogen Sulfide on Balloon Injury-Induced Neointima Hyperplasia in Rat Carotid Arteries
Am. J. Pathol., April 1, 2007; 170(4): 1406 - 1414.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Rocic, B. Rezk, and P. A. Lucchesi
PPAR-{gamma} agonists decrease hyperhomcysteinemia and cardiac dysfunction: new hope for ailing diabetic hearts?
Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H26 - H28.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. W.H. Woo, Y. L. Siow, and K. O
Homocysteine Activates cAMP-response Element Binding Protein in HepG2 Through cAMP/PKA Signaling Pathway
Arterioscler. Thromb. Vasc. Biol., May 1, 2006; 26(5): 1043 - 1050.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. M. Devlin and S. R. Lentz
ApoA-I: A Missing Link Between Homocysteine and Lipid Metabolism?
Circ. Res., March 3, 2006; 98(4): 431 - 433.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
O. Postea, F. Krotz, A. Henger, C. Keller, and N. Weiss
Stereospecific and Redox-Sensitive Increase in Monocyte Adhesion to Endothelial Cells by Homocysteine
Arterioscler. Thromb. Vasc. Biol., March 1, 2006; 26(3): 508 - 513.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Csiszar, M. Ahmad, K. E. Smith, N. Labinskyy, Q. Gao, G. Kaley, J. G. Edwards, M. S. Wolin, and Z. Ungvari
Bone Morphogenetic Protein-2 Induces Proinflammatory Endothelial Phenotype
Am. J. Pathol., February 1, 2006; 168(2): 629 - 638.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Tan, X. Jiang, F. Yang, Z. Li, D. Liao, J. Trial, M. J. Magera, W. Durante, X. Yang, and H. Wang
Hyperhomocysteinemia inhibits post-injury reendothelialization in mice
Cardiovasc Res, January 1, 2006; 69(1): 253 - 262.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Csiszar, K. E. Smith, A. Koller, G. Kaley, J. G. Edwards, and Z. Ungvari
Regulation of Bone Morphogenetic Protein-2 Expression in Endothelial Cells: Role of Nuclear Factor-{kappa}B Activation by Tumor Necrosis Factor-{alpha}, H2O2, and High Intravascular Pressure
Circulation, May 10, 2005; 111(18): 2364 - 2372.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. W. H. Woo, Y. L. Siow, G. N. Pierce, P. C. Choy, G. Y. Minuk, D. Mymin, and K. O
Hyperhomocysteinemia induces hepatic cholesterol biosynthesis and lipid accumulation via activation of transcription factors
Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E1002 - E1010.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Jaramillo, M. Godbout, and M. Olivier
Hemozoin Induces Macrophage Chemokine Expression through Oxidative Stress-Dependent and -Independent Mechanisms
J. Immunol., January 1, 2005; 174(1): 475 - 484.
[Abstract] [Full Text] [PDF]